Orbimed Advisors LLC Alx Oncology Holdings Inc Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Orbimed Advisors LLC holds 2,717,970 shares of ALXO stock, worth $16.4 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
2,717,970
Previous 3,095,000
12.18%
Holding current value
$16.4 Million
Previous $46.1 Million
34.24%
% of portfolio
0.68%
Previous 1.13%
Shares
7 transactions
Others Institutions Holding ALXO
# of Institutions
115Shares Held
38.4MCall Options Held
132KPut Options Held
19.7K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$58.5 Million42.27% of portfolio
-
Redmile Group, LLC San Francisco, CA4.33MShares$26.1 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.22MShares$25.4 Million6.29% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.14MShares$18.9 Million2.02% of portfolio
-
Vestal Point Capital, LP New York, NY2.61MShares$15.7 Million2.41% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $246M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...